Nintedanib Sandoz 100 mg
Nintedanib Sandoz 100 mg is a medicine authorised by Swissmedic under authorisation number 70120. The authorisation holder is Sandoz Pharmaceuticals AG. The medicinal product code is Synthetic medicines and the dispensing category is B: Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly. First authorisation was granted on 14 August 2025 and the authorisation is limited until 13 August 2030. ATC code L01EX09 places the medicine in the group Antineoplastic agents.
| Authorisation number | 70120 |
|---|---|
| Name | Nintedanib Sandoz 100 mg |
| Full name | Nintedanib Sandoz 100 mg, Weichkapseln |
| Authorisation holder | Sandoz Pharmaceuticals AG |
| Medicinal product code | Synthetic medicines |
| Dispensing category | B · Prescription only |
| ATC code | L01EX09 |
| First authorisation | 14 August 2025 |
| Authorisation validity | 13 August 2030 |
| No. | Name | Dispensing category | Authorisation date |
|---|---|---|---|
| 1 | Nintedanib Sandoz 100 mg, Weichkapseln | B | 14 August 2025 |
| 3 | Nintedanib Sandoz 150 mg, Weichkapseln | B | 14 August 2025 |
Scroll the table sideways
| Pack code | Quantity | Unit | ATC | IT code | Dispensing category |
|---|---|---|---|---|---|
| 1 | 60 | Kapsel(n) | L01EX09 | 03.99.0. | B |
| 2 | 60 | Kapsel(n) | L01EX09 | 03.99.0. | B |
Scroll the table sideways
Medicines in the same ATC group
Other medicines from this authorisation holder
Frequently asked questions
Is Nintedanib Sandoz 100 mg authorised in Switzerland?
Yes. Nintedanib Sandoz 100 mg is authorised by Swissmedic under authorisation number 70120, data as of 01 September 2026. The authorisation is limited until 13 August 2030.
Which dispensing category does Nintedanib Sandoz 100 mg have?
Nintedanib Sandoz 100 mg is in dispensing category B. Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly.
Who is the authorisation holder of Nintedanib Sandoz 100 mg?
The authorisation holder is Sandoz Pharmaceuticals AG. The holder carries the legal responsibility for quality, safety and product information of the medicine in Switzerland.
Sources
Swissmedic data as of 01 September 2026. No medical advice. Independent directory, not affiliated with Swissmedic or the FOPH.